Autism Research Institute
Autism Research Review International
1987 to 2006, Volumes 1 to 20
a b c d e f g h i j k l m n o p q r s t u v w x y z
C
c-Fos protein, 2001, Vol. 15(4) pp. 2
Cade, J. Robert, 1999, Vol. 13(2) pp. 1
Cadet, Jean Lud, 1992, Vol. 06(2) pp. 7; 1994, Vol. 08(3) pp. 1.
cadmium poisoning, 2002, Vol. 16(3) pp. 4; 2003, Vol. 17(3) pp. 1; 2006, Vol. 20(1) pp. 3; 2006, Vol. 20(4) pp. 1.
Cafiero, Joanne M., 1997, Vol. 11(1) pp. 6
CAH. See congenital adrenal hyplasia
calcium
for aggression, 1998, Vol. 12(3) pp. 6
and dendritic cell channels, 2006, Vol. 20(1) pp. 1
and dopamine, 1995, Vol. 09(1) pp. 4
for expressive speech, 1990, Vol. 04(1) pp. 2
and parathyroid hormone, 1998, Vol. 12(3) pp. 6
for PMS, 1998, Vol. 12(3) pp. 6; 2005, Vol. 19(2) pp. 4.
for seizures, 1990, Vol. 04(1) pp. 2
for self-injury, 1990, Vol. 04(1) pp. 2; 1995, Vol. 09(1) pp. 4; 1998, Vol. 12(3) pp. 6; 2002, Vol. 16(2) pp. 7.
and serotonin, 1995, Vol. 09(1) pp. 4
calcium pangamate (vitamin B15), 1990, Vol. 04(2) pp. 3
calculating savants, 1989, Vol. 03(1) pp. 1
Calculator, Stephen, 1992, Vol. 06(4) pp. 3
calendar savants, 1989, Vol. 03(1) pp. 1–2
California, 2000, Vol. 14(2) pp. 1; 2001, Vol. 15(1) pp. 2; 2001, Vol. 15(3) pp. 2; 2004, Vol. 18(4) pp. 3; 2005, Vol. 19(2) pp. 1.
California Birth Defects Monitoring Program (CBDMP), 2000, Vol. 14(2) pp. 1
California Department of Developmental Services (DDS), 2001, Vol. 15(1) pp. 2; 2002, Vol. 16(4) pp. 1; 2003, Vol. 17(1) pp. 1; 2003, Vol. 17(3) pp. 2; 2006, Vol. 20(1) pp. 2.
California Epidemiology Report, 2002, Vol. 16(3) pp. 1
Caligiuri, Michael P., 1996, Vol. 10(2) pp. 5
Callahan, Mary, 1989, Vol. 03(2) pp. 3; 1989, Vol. 03(3) pp. 6; 1992, Vol. 06(1) pp. 7.
Callahan family, 1993, Vol. 07(3) pp. 3
Callaway, Enoch, 1987, Vol. 01(4) pp. 3; 2000, Vol. 14(3) pp. 3.
Calvert, Sandra, 2000, Vol. 14(4) pp. 5
Cambridgeshire (U.K.), 2000, Vol. 14(2) pp. 1
Campbell, Daniel B., 2006, Vol. 20(4) pp. 4
Campbell, Magda
fenfluramine study, 1987, Vol. 01(3) pp. 2
naltrexone studies, 1987, Vol. 01(2) pp. 1; 1989, Vol. 03(3) pp. 1; 1990, Vol. 04(4) pp. 4; 1991, Vol. 05(4) pp. 2; 1994, Vol. 08(1) pp. 4.
on panaceas for autism, 1990, Vol. 04(1) pp. 1–2
Campbell, Phillip, 1995, Vol. 09(4) pp. 2; 1997, Vol. 11(3) pp. .
Camphill villages, 1990, Vol. 04(3) pp. 3
Canada and inclusion, 1995, Vol. 09(4) pp. 7
cancer, 1995, Vol. 09(1) pp. 2; 1997, Vol. 11(3) pp. 6; 1998, Vol. 12(2) pp. 3; 2001, Vol. 15(4) pp. 6; 2005, Vol. 19(1) pp. 6.
candida albicans, 1988, Vol. 02(2) pp. 3; 1988, Vol. 02(4) pp. 6; 1989, Vol. 03(1) pp. 6; 1995, Vol. 09(3) pp. 3; 2003, Vol. 17(1) pp. 7; 2004, Vol. 18(2) pp. 7.
CANDLE (Childhood Aphasia, Neurological Disorders, Landau-Kleffner Syndrome and Epilepsy), 1991, Vol. 05(1) pp. 1; 1992, Vol. 06(1) pp. 6; 1995, Vol. 09(1) pp. 6; 1995, Vol. 09(2) pp. 2.
Canine Companions for Independence, 1989, Vol. 03(4) pp. 2
cannabinoids, 2005, Vol. 19(1) pp. 4. See also marijuana, Marinol, THC
cannabis. See marijuana, Marinol
Canon Communicator, 1988, Vol. 02(1) pp. 3; 1988, Vol. 02(3) pp. 7; 1990, Vol. 04(4) pp. 1; 1991, Vol. 05(1) pp. 1; 1994, Vol. 08(4) pp. 3.
Cantekin, Erdem, 1992, Vol. 06(4) pp. 4; 1997, Vol. 11(1) pp. 7.
Cantero, Julio, 2003, Vol. 17(1) pp. 4
Cantor, David S., 1998, Vol. 12(3) pp. 2
Cantor, Rita M., 2005, Vol. 19(3) pp. 6
Capelle, P., 1987, Vol. 01(4) pp. 4; 1988, Vol. 02(4) pp. 7.
Cappas, William, 1993, Vol. 07(2) pp. 7
caprylic acid, 1988, Vol. 02(2) pp. 3
carbamazepine (Tegretol)
for aggression, 1990, Vol. 04(2) pp. 2; 1992, Vol. 06(4) pp. 7.
and aplastic anemia, 1994, Vol. 08(3) pp. 2
for behavior problems, 1990, Vol. 04(2) pp. 2; 1993, Vol. 07(4) pp. 5; 1996, Vol. 10(2) pp. 6.
and contraceptives, 1996, Vol. 10(3) pp. 4
and dental disease, 1998, Vol. 12(1) pp. 7
and fluvoxamine, 1995, Vol. 09(4) pp. 1
for hyperactivity, 1990, Vol. 04(2) pp. 2
moisture's effects on, 1990, Vol. 04(1) pp. 6
for seizures, 1993, Vol. 07(4) pp. 5; 1996, Vol. 10(2) pp. 6.
for self-injury, 1990, Vol. 04(2) pp. 2
for tantrums, 1990, Vol. 04(2) pp. 2
carboxyethylpyrrole, 2005, Vol. 19(2) pp. 2
carboxylase, 1987, Vol. 01(2) pp. 7
CARD (Center for Autism and Related Disorders), 2004, Vol. 18(3) pp. 3
cardiac abnormalities
from ADHD drugs, 2006, Vol. 20(1) pp. 5; 2006, Vol. 20(2) pp. 2.
from anticonvulsants, 2003, Vol. 17(1) pp. 5; 2005, Vol. 19(4) pp. 7.
from antipsychotics, 2005, Vol. 19(1) pp. 6
arrhythmias, 2002, Vol. 16(4) pp. 6
atherosclerotic vascular disease, 2003, Vol. 17(1) pp. 5
from Atkins diet, 2004, Vol. 18(1) pp. 2
and clomipramine, 1993, Vol. 07(4) pp. 1
and clonidine, 1992, Vol. 06(3) pp. 2; 1996, Vol. 10(1) pp. 7; 2000, Vol. 14(1) pp. 4.
and clozapine, 2002, Vol. 16(1) pp. 4
and desipramine, 1995, Vol. 09(4) pp. 4
from divalproex sodium, 2005, Vol. 19(4) pp. 4
fenfluramine lawsuits, 2002, Vol. 16(4) pp. 2
and homocysteine, 2005, Vol. 19(4) pp. 7
long QT syndrome, 2002, Vol. 16(1) pp. 5
from marjuana, 2003, Vol. 17(1) pp. 3
and methylphenidate (Ritalin), 1996, Vol. 10(1) pp. 7
myocarditis, 2002, Vol. 16(1) pp. 4
and pimozide (ORAP), 2000, Vol. 14(1) pp. 4
and risperidone, 1996, Vol. 10(1) pp. 7; 1997, Vol. 11(3) pp. 2; 1998, Vol. 12(2) pp. 4; 2000, Vol. 14(1) pp. 5; 2001, Vol. 15(2) pp. 4; 2002, Vol. 16(4) pp. 7; 2003, Vol. 17(1) pp. 6.
and Ritalin, 2005, Vol. 19(3) pp. 3
strokes, 2003, Vol. 17(1) pp. 6
supplements for, 1993, Vol. 07(2) pp. 1; 1997, Vol. 11(3) pp. 3.
from thimerosol, 2003, Vol. 17(1) pp. 2
and ziprazidone, 2004, Vol. 18(1) pp. 6
Cardinal, Don, 1994, Vol. 08(1) pp. 7; 1994, Vol. 08(2) pp. 2.
Carlezon, William A., 2004, Vol. 18(4) pp. 5
Carlson, Jane I., 1993, Vol. 07(4) pp. 5
Carlson, Karen, 1992, Vol. 06(1) pp. 7
Carmody, Dennis P., 2001, Vol. 15(2) pp. 5
Carnegie, Dale, 1994, Vol. 08(3) pp. 6
Carney, B.T., 2005, Vol. 19(4) pp. 4
carnitine. See L-carnitine
carnosine. See L-carnosine
Carpenter, P. K., 1990, Vol. 04(3) pp. 4
Carr, Edward G., 1988, Vol. 02(2) pp. 2; 1988, Vol. 02(3) pp. 3; 1990, Vol. 04(2) pp. 6; 1992, Vol. 06(1) pp. 5.
Carratala, F., 1998, Vol. 12(3) pp. 4
CARS (Childhood Autism Rating Scale), 2005, Vol. 19(3) pp. 5
Caruso, Jane M., 2001, Vol. 15(1) pp. 4
Casanova, Manuel F., 2002, Vol. 16(1) pp. 1
casein
casein-free diet
for agitation, 2002, Vol. 16(3) pp. 1
for autistic symptoms, 1996, Vol. 10(3) pp. 4; 1997, Vol. 11(1) pp. 6; 2001, Vol. 15(3) pp. 4; 2002, Vol. 16(3) pp. 1; 2004, Vol. 18(4) pp. 2; 2005, Vol. 19(4) pp. 7.
for ear infections, 1994, Vol. 08(4) pp. 2; 1997, Vol. 11(1) pp. 7.
enzymes for, 2002, Vol. 16(1) pp. 3; 2002, Vol. 16(2) pp. 4.
and eosinophils, 2003, Vol. 17(4) pp. 1
Lisa Lewis paper, 1994, Vol. 08(3) pp. 7; 1995, Vol. 09(3) pp. 7.
for peptidase deficiencies, 1991, Vol. 05(4) pp. 2; 1992, Vol. 06(1) pp. 7; 1993, Vol. 07(1) pp. 4; 1995, Vol. 09(4) pp. 5; 1999, Vol. 13(2) pp. 1.
for perseveration, 1997, Vol. 11(1) pp. 6
and Specific Carbohydrate Diet, 2004, Vol. 18(4) pp. 2
website on, 2002, Vol. 16(1) pp. 3
for weight gain, 1993, Vol. 07(4) pp. 5–6
Caston, J., 1998, Vol. 12(4) pp. 4
CAT/CLAMS (Cognitive Adaptive Test/ Clinical Linguistic Auditory Milestone Scale) test, 2003, Vol. 17(1) pp. 7
catalase, 2005, Vol. 19(2) pp. 6
Catanese, Tony, 1991, Vol. 05(1) pp. 6; 1991, Vol. 05(2) pp. 6.
catatonia, 2000, Vol. 14(4) pp. 4
catecholamines, 1987, Vol. 01(4) pp. 6; 2004, Vol. 18(4) pp. 4.
Cathcart, Kristina, 1998, Vol. 12(2) pp. 5; 1998, Vol. 12(3) pp. 7.
Cathcart, Robert, 1998, Vol. 12(2) pp. 3
cattle measles vaccine, 2002, Vol. 16(1) pp. 6
caudate nuclei, abnormalities in, 1989, Vol. 03(4) pp. 4; 1996, Vol. 10(1) pp. 5; 1997, Vol. 11(4) pp. 4; 2004, Vol. 18(1) pp. 6.
Cautela, Joseph, 1988, Vol. 02(4) pp. 5
Cave, Stephanie, 2000, Vol. 14(4) pp. 3
CB1 receptor, 2003, Vol. 17(4) pp. 4
CBS Network, 1994, Vol. 08(3) pp. 7
CD2 1992, Vol. 06(4) pp. 4
CD6 1995, Vol. 09(4) pp. 4
CDC. See Centers for Disease Control and Prevention
CDD (Childhood Disintegrative Disorder) Network, 1996, Vol. 10(1) pp. 4
Cecil, Kim M., 2003, Vol. 17(3) pp. 4
cefaclor, 1992, Vol. 06(4) pp. 4
Celexa (citalopram), 2004, Vol. 18(3) pp. 6
Celiac/Autism Package (ARI), 1995, Vol. 09(3) pp. 7
Celiac Discussion Group, 1994, Vol. 08(4) pp. 7; 1995, Vol. 09(3) pp. 7.
celiac disease
autistic symptoms from, 2002, Vol. 16(3) pp. 2
and epilepsy, 1993, Vol. 07(1) pp. 4
gluten-free diet caveats, 1995, Vol. 09(3) pp. 7
and gut epithelial dysfunction, 2001, Vol. 15(1) pp. 2
and lead poisoning, 2004, Vol. 18(1) pp. 4
and phenol intolerance compared, 1995, Vol. 09(4) pp. 6
and schizophrenia, 2004, Vol. 18(1) pp. 4
website on, 1995, Vol. 09(3) pp. 7; 1996, Vol. 10(3) pp. 7.
and zonulin, 2000, Vol. 14(2) pp. 2
Celiac List, 1996, Vol. 10(3) pp. 7
cell abnormalities in muscle mitochondria, 1989, Vol. 03(4) pp. 4; 1990, Vol. 04(1) pp. 4.
cell death, 2005, Vol. 19(2) pp. 4; 2006, Vol. 20(1) pp. 5.
cell therapy, 1997, Vol. 11(3) pp. 3
Center, David B., 1996, Vol. 10(4) pp. 5
Center for Autism and Related Disorders (CARD), 2004, Vol. 18(3) pp. 3
Center for Neurodevelopmental Studies (Phoenix, AZ), 1991, Vol. 05(2) pp. 6
Center for Science in the Public Interest, 2003, Vol. 17(3) pp. 3
Centers for Disease Control and Prevention (CDC)
Advisory Committee on Immunization Practices and drug companies, 2000, Vol. 14(3) pp. 7
autism clusters, 1999, Vol. 13(1) pp. 1; 1999, Vol. 13(2) pp. 3; 2002, Vol. 16(4) pp. 1.
on drug death blamed on chelation, 2005, Vol. 19(3) pp. 3
epidemic of autism, 2002, Vol. 16(4) pp. 1; 2003, Vol. 17(3) pp. 2.
mercury and neurological disorders study, 2000, Vol. 14(3) pp. 1; 2001, Vol. 15(4) pp. 1; 2003, Vol. 17(1) pp. 7; 2003, Vol. 17(2) pp. 7.
National Immunization Program, 2006, Vol. 20(1) pp. 2
Thimerosol Vaccine Safety Datalink, 2003, Vol. 17(1) pp. 1
vaccination schedules, 1995, Vol. 09(1) pp. 1
vaccine coverup, 2002, Vol. 16(2) pp. 1; 2002, Vol. 16(3) pp. 3; 2003, Vol. 17(2) pp. 2; 2004, Vol. 18(2) pp. 3.
central conduction times (CCTs), 1992, Vol. 06(4) pp. 1
Ceponiene, Rita, 2003, Vol. 17(2) pp. 4
cerebellum abnormalities, 1987, Vol. 01(3) pp. 3
and anti-brain antibodies, 2004, Vol. 18(1) pp. 6; 2004, Vol. 18(4) pp. 1.
in Asperger's, 1995, Vol. 09(4) pp. 5
assymetries of serotonin synthesis in dentate nucleus, 1995, Vol. 09(4) pp. 5
and attention difficulties, 1994, Vol. 08(2) pp. 1; 1996, Vol. 10(1) pp. 4; 1997, Vol. 11(2) pp. 4.
in autistics' brains, 1997, Vol. 11(1) pp. 1
and brainstem, 1987, Vol. 01(1) pp. 1; 1992, Vol. 06(4) pp. 1.
and cerebral cortex, 1999, Vol. 13(2) pp. 2
and cognitive deficits, 1996, Vol. 10(1) pp. 4
in Down's syndrome and autism, 1993, Vol. 07(2) pp. 4
and exploration decrease, 2000, Vol. 14(3) pp. 4
and eye movement, 1988, Vol. 02(4) pp. 4
and facial expression recognition, 2000, Vol. 14(4) pp. 2
and fetal alcohol syndrome, 1992, Vol. 06(4) pp. 5
and Fragile X, 1988, Vol. 02(4) pp. 1
granule neuron cytotoxins, 2003, Vol. 17(4) pp. 1
hypoplasia, 2001, Vol. 15(2) pp. 1
lenses for, 1996, Vol. 10(4) pp. 4
lesions and handwriting, 2001, Vol. 15(3) pp. 5
from mercury poisoning and autism compared, 2000, Vol. 14(2) pp. 7
and motor difficulties, 1997, Vol. 11(2) pp. 4
NAA (N-acetyl-aspartate) levels, 1999, Vol. 13(4) pp. 4
and neuropathy target esterase (NTE) deficiency, 2003, Vol. 17(1) pp. 6
from prenatal stress, 2001, Vol. 15(4) pp. 7
in Purkinje cells, 1989, Vol. 03(1) pp. 4; 1998, Vol. 12(4) pp. 6; 2000, Vol. 14(3) pp. 5; 2001, Vol. 15(4) pp. 2; 2002, Vol. 16(3) pp. 4; 2003, Vol. 17(1) pp. 6; 2004, Vol. 18(4) pp. 1; 2006, Vol. 20(4) pp. 1.
and reduced cell count, 1989, Vol. 03(3) pp. 4
and reelin, 2001, Vol. 15(2) pp. 1
and saccades, 2004, Vol. 18(3) pp. 4
secretin for, 2001, Vol. 15(4) pp. 2; 2004, Vol. 18(2) pp. 2.
and terbutaline, 2004, Vol. 18(3) pp. 6
from thimerosol, 2003, Vol. 17(4) pp. 1
and toxics, 2006, Vol. 20(4) pp. 1
and valproic acid, 2000, Vol. 14(3) pp. 5
and ventricular enlargement, 1990, Vol. 04(1) pp. 4
and vermal lobule abnormalities, 1988, Vol. 02(2) pp. 1; 1991, Vol. 05(2) pp. 4; 1994, Vol. 08(2) pp. 1; 2001, Vol. 15(4) pp. 4.
and vermis defects, 1995, Vol. 09(2) pp. 1
and vision problems, 1996, Vol. 10(4) pp. 4
in Williams syndrome and autism, 1994, Vol. 08(2) pp. 4
cerebral cortex, 1993, Vol. 07(2) pp. 4; 1999, Vol. 13(2) pp. 2; 2001, Vol. 15(2) pp. 1; 2001, Vol. 15(3) pp. 7; 2004, Vol. 18(1) pp. 6; 2005, Vol. 19(4) pp. 2.
cerebral gigantism, 1990, Vol. 04(4) pp. 5
cerebral palsy, 1995, Vol. 09(1) pp. 4; 1999, Vol. 13(2) pp. 7; 1999, Vol. 13(3) pp. 4; 2002, Vol. 16(3) pp. 7.
cerebrolysin, 2003, Vol. 17(3) pp. 5
cerebrospinal fluid abnormalities, 1997, Vol. 11(1) pp. 1
cerebrovascular disease, 2002, Vol. 16(4) pp. 7
cerebrum
allergy in, 1989, Vol. 03(2) pp. 3
blood flow in, 1997, Vol. 11(1) pp. 2
calcification of, 1993, Vol. 07(1) pp. 4
cortical defects in, 1990, Vol. 04(3) pp. 4; 1993, Vol. 07(2) pp. 4; 1999, Vol. 13(2) pp. 2; 2001, Vol. 15(2) pp. 1; 2001, Vol. 15(3) pp. 7.
Cerioli, Mario, 1988, Vol. 02(4) pp. 4; 1990, Vol. 04(4) pp. 6.
Cerreto, Mary, 1995, Vol. 09(4) pp. 2
Cesaroni, Laura, 1991, Vol. 05(4) pp. 7
Chaffee bill, 1990, Vol. 04(3) pp. 3
Chakrabarti, Suniti, 2001, Vol. 15(2) pp. 1; 2005, Vol. 19(2) pp. 6.
challenge method of toilet training, 1995, Vol. 09(3) pp. 2
challenge tests, 2006, Vol. 20(1) pp. 3
Chamberlain, Ronald, 1991, Vol. 05(2) pp. 5; 1993, Vol. 07(3) pp. 4.
Chandra, R. K., 1998, Vol. 12(1) pp. 3
Chandran, K., 1996, Vol. 10(1) pp. 7
Chang, S.
Charlie Foundation to Help Cure Pediatric Epilepsy, 1996, Vol. 10(1) pp. 5
Charlop, Marjorie H., 1987, Vol. 01(2) pp. 5; 1990, Vol. 04(1) pp. 5; 1991, Vol. 05(1) pp. 5.
Charlop-Christy, Marjorie H., 2002, Vol. 16(4) pp. 2; 2003, Vol. 17(1) pp. 5.
chaste tree berry (agnus castus), 2001, Vol. 15(1) pp. 4
CHAT (Checklist for Autism in Toddlers), 1993, Vol. 07(1) pp. 1; 1996, Vol. 10(2) pp. 6.
Chauhan, Abha, 2005, Vol. 19(2) pp. 6
Chauhan, Ved, 2005, Vol. 19(2) pp. 6
Cheerful Chemist's No Casein, No Gluten, No Sugar Optional Cookbook (Ramsey), 2000, Vol. 14(3) pp. 6–7
chelation therapy, 1994, Vol. 08(1) pp. 5; 2003, Vol. 17(3) pp. 1; 2004, Vol. 18(3) pp. 3; 2005, Vol. 19(1) pp. 2; 2005, Vol. 19(3) pp. 1; 2006, Vol. 20(1) pp. 3; 2006, Vol. 20(2) pp. 1; 2006, Vol. 20(3) pp. 7.
chemokines, 2004, Vol. 18(4) pp. 1
chemotherapy and communication, 1992, Vol. 06(4) pp. 3
Chen, L., 2001, Vol. 15(3) pp. 4
Chen, Robert T., 1998, Vol. 12(1) pp. 3
chewing gum, 1998, Vol. 12(4) pp. 4; 2000, Vol. 14(3) pp. 6.
Chez, Michael, 2005, Vol. 19(3) pp. 7
Chez, Michael G., 1999, Vol. 13(1) pp. 3; 2000, Vol. 14(2) pp. 3; 2003, Vol. 17(1) pp. 1; 2004, Vol. 18(2) pp. 5.
Chicago Reader, 1990, Vol. 04(4) pp. 6
Chicago Tribune, 2005, Vol. 19(4) pp. 6
child abuse system, 1993, Vol. 07(1) pp. 7; 1993, Vol. 07(2) pp. 6.
Child Neurology Society, 2000, Vol. 14(3) pp. 4
Childhood Autism Rating Scale, 1992, Vol. 06(3) pp. 5; 2005, Vol. 19(3) pp. 5.
childhood disintegrative disorder (CDD), 1996, Vol. 10(1) pp. 4
children and psych drugs, 2004, Vol. 18(2) pp. 4
Children with Autism: A Parents' Guide (Powers), 1990, Vol. 04(1) pp. 7
Children with Starving Brains: A Medical Treatment Guide for Autism Spectrum Disorder (McCandless), 2002, Vol. 16(2) pp. 3
Children's Center for Neurodevelopmental Studies, 2006, Vol. 20(3) pp. 5
Chin-Perez, G., 1988, Vol. 02(1) pp. 7; 1994, Vol. 08(4) pp. 6.
Chisholm, Martha, 1997, Vol. 11(1) pp. 5
chloral hydrate, 1991, Vol. 05(1) pp. 4
chlorpromazine (Thorazine), 1989, Vol. 03(3) pp. 4; 2000, Vol. 14(4) pp. 4.
choice. See also self-determination
choice making, 1994, Vol. 08(1) pp. 2; 1994, Vol. 08(3) pp. 5.
choking from drugs, 2003, Vol. 17(4) pp. 5
cholestatic hepatitis, 2005, Vol. 19(3) pp. 3
cholesterol, 2006, Vol. 20(2) pp. 5
choline, 2005, Vol. 19(4) pp. 3
cholinergic abnormalities, 2001, Vol. 15(3) pp. 7
Chow, Billy K. C., 2001, Vol. 15(4) pp. 2
Christiansen, Stephen P., 1998, Vol. 12(3) pp. 4
chromium, 2006, Vol. 20(4) pp. 6
chromosomal defects. See genetic factors
chronic fatigue syndrome, 1999, Vol. 13(2) pp. 3
Chudley, Albert E., 1999, Vol. 13(1) pp. 6
Chugani, Diane C., 1997, Vol. 11(4) pp. 4; 1999, Vol. 13(3) pp. 7; 1999, Vol. 13(4) pp. 4; 2001, Vol. 15(4) pp. 4.
Church, Catharine Critz, 1995, Vol. 09(2) pp. 6
chymotrysin, 2001, Vol. 15(2) pp. 1
Ciaranello, Roland, 1987, Vol. 01(2) pp. 2; 1988, Vol. 02(2) pp. 4; 1992, Vol. 06(2) pp. 1; 1995, Vol. 09(1) pp. 2.
cigarette pica, 1999, Vol. 13(4) pp. 5
cingulate gyrus, 1996, Vol. 10(1) pp. 5
cingulotomy, 1995, Vol. 09(2) pp. 1
Cipani, Ennio, 1988, Vol. 02(1) pp. 5; 1994, Vol. 08(4) pp. 5.
circadian rhythms, 1994, Vol. 08(2) pp. 6; 1994, Vol. 08(3) pp. 2.
citalopram (Celexa), 2004, Vol. 18(3) pp. 6
Citizens for Health, 1992, Vol. 06(2) pp. 3; 1994, Vol. 08(3) pp. 7.
citrus fruits, 2005, Vol. 19(1) pp. 3
Civil Rights Office, 1993, Vol. 07(4) pp. 2
Clark, Joseph H., 1993, Vol. 07(4) pp. 4; 1998, Vol. 12(3) pp. 4.
Clark, Lujene, 2004, Vol. 18(4) pp. 3
Clarke, Robin P. M., 1993, Vol. 07(1) pp. 5; 1997, Vol. 11(4) pp. 6.
classical autism, 1999, Vol. 13(2) pp. 2
classroom. See education
clavulanate, 2005, Vol. 19(1) pp. 6
Clemetson, Alan B., 2000, Vol. 14(1) pp. 5
Clemmons, Alonzo, 1989, Vol. 03(1) pp. 1
Cleveland, P.W., 1991, Vol. 05(3) pp. 6
"Clever Hans" effect, 1992, Vol. 06(3) pp. 7
Clinical Assessment Options for Children with Autism and Related Disorders (compiled and ed. Baker and Pangborn), 2000, Vol. 14(3) pp. 4; 2001, Vol. 15(1) pp. 3; 2002, Vol. 16(2) pp. 3.
Clinical Global Consensus Ratings, 1996, Vol. 10(3) pp. 1
clomipramine (Anafranil)
for aggression, 1998, Vol. 12(1) pp. 4
and agitation, 1998, Vol. 12(1) pp. 4
and desipramine compared, 1992, Vol. 06(2) pp. 7; 1993, Vol. 07(4) pp. 1.
for obsessive-compulsive disorder, 1992, Vol. 06(2) pp. 7; 1992, Vol. 06(4) pp. 5; 1993, Vol. 07(3) pp. 1; 1993, Vol. 07(4) pp. 1; 1996, Vol. 10(3) pp. 6.
for property destruction, 1998, Vol. 12(1) pp. 4
rages from, 1993, Vol. 07(3) pp. 1; 1993, Vol. 07(4) pp. 1; 1996, Vol. 10(3) pp. 6.
for repetitive behaviors, 2000, Vol. 14(2) pp. 4
for ritualistic behaviors, 1996, Vol. 10(3) pp. 6; 1998, Vol. 12(1) pp. 4.
and self-injury, 1996, Vol. 10(3) pp. 1; 1996, Vol. 10(4) pp. 4; 1998, Vol. 12(1) pp. 4.
and serotonin, 1993, Vol. 07(4) pp. 1
for sociability, 1996, Vol. 10(3) pp. 6; 1996, Vol. 10(4) pp. 4; 1998, Vol. 12(1) pp. 4.
for speech, 1993, Vol. 07(3) pp. 1
for stereotypies, 1993, Vol. 07(3) pp. 1; 1993, Vol. 07(4) pp. 1; 1996, Vol. 10(3) pp. 6.
for tantrums, 1993, Vol. 07(3) pp. 1
clonazepam, 1996, Vol. 10(2) pp. 6
clonidine (Catapres)
and cardiac abnormalities, 1992, Vol. 06(3) pp. 2; 1996, Vol. 10(1) pp. 7; 2000, Vol. 14(1) pp. 4.
and EKG abnormalities, 1996, Vol. 10(1) pp. 7
and norepinephrine, 2000, Vol. 14(1) pp. 4
and Risperdal compared, 1995, Vol. 09(4) pp. 4
for self-injuring behaviors, 2000, Vol. 14(1) pp. 4
for social and communication deficits, 1992, Vol. 06(3) pp. 2
for Tourette's, 1992, Vol. 06(3) pp. 2
clostridium botulinum, 2000, Vol. 14(3) pp. 4
Clostridium tetani, 1998, Vol. 12(4) pp. 1; 2000, Vol. 14(3) pp. 2.
clozapine (Clozaril)
for aggression, 1996, Vol. 10(1) pp. 1; 1996, Vol. 10(3) pp. 2.
and agranulocytosis, 1996, Vol. 10(1) pp. 1; 1996, Vol. 10(3) pp. 2.
and akathisia, 2006, Vol. 20(2) pp. 2
and blood clots, 2000, Vol. 14(4) pp. 4
and cardiac abnormalities, 2002, Vol. 16(1) pp. 4
and diabetes, 1999, Vol. 13(3) pp. 2; 2002, Vol. 16(2) pp. 6; 2002, Vol. 16(4) pp. 6; 2003, Vol. 17(3) pp. 2; 2004, Vol. 18(2) pp. 2; 2005, Vol. 19(3) pp. 4.
and dopamine receptors, 1996, Vol. 10(1) pp. 1
and hyperactivity, 1996, Vol. 10(3) pp. 2
hyperlipidemia from, 2005, Vol. 19(1) pp. 6
hyperprolactinemia from, 2001, Vol. 15(2) pp. 4
and Korean Americans, 2000, Vol. 14(1) pp. 4
and myocarditis, 2002, Vol. 16(1) pp. 4
and seizures, 1996, Vol. 10(1) pp. 1; 1996, Vol. 10(3) pp. 2.
for self-injury, 1996, Vol. 10(1) pp. 1; 1996, Vol. 10(3) pp. 2.
Clozaril. See clozapine (Clozaril)
clumsiness, 1995, Vol. 09(2) pp. 6; 2005, Vol. 19(4) pp. 7.
CMV (cytomegalovirus), 1990, Vol. 04(4) pp. 4; 1991, Vol. 05(4) pp. 2.
co-morbid disorders, 1988, Vol. 02(1) pp. 1; 1989, Vol. 03(2) pp. 6; 1996, Vol. 10(3) pp. 5.
Coalition for SAFE Minds, 2000, Vol. 14(4) pp. 7; 2001, Vol. 15(3) pp. 1; 2001, Vol. 15(4) pp. 1; 2002, Vol. 16(4) pp. 1.
Coastal Compounding, 2005, Vol. 19(2) pp. 2
Cochrane, Victoria, 1991, Vol. 05(3) pp. 5; 1992, Vol. 06(1) pp. 5.
cod liver oil, 2000, Vol. 14(1) pp. 6; 2000, Vol. 14(2) pp. 7; 2002, Vol. 16(3) pp. 7.
coenzyme Q10, 1999, Vol. 13(4) pp. 4
Cogentin, 1992, Vol. 06(2) pp. 5
Coggans, Maryanne, 1995, Vol. 09(4) pp. 7
Coggins, Truman, E., 1988, Vol. 02(4) pp. 2
cognitive impairments
and DHA deficiency, 2004, Vol. 18(2) pp. 4
diets for, 2002, Vol. 16(3) pp. 1
from divalproex sodium, 2005, Vol. 19(4) pp. 4
from Epstein-Barr infection, 2001, Vol. 15(1) pp. 4
HUFAs (highly unsaturated fatty acids) for, 2002, Vol. 16(1) pp. 4
from mercury in mining areas, 2003, Vol. 17(1) pp. 7
naltrexone (low-dose) for, 2005, Vol. 19(2) pp. 2; 2006, Vol. 20(2) pp. 5.
in reasoning, 2000, Vol. 14(3) pp. 1
cognitive impairments or differences
Cohan, Tracy, 1990, Vol. 04(3) pp. 1
Cohen, Donald, 1988, Vol. 02(4) pp. 7
Cohen, Ira, 1990, Vol. 04(1) pp. 1; 1994, Vol. 08(3) pp. 3; 1995, Vol. 09(1) pp. 5.
Coker, Steven, 1991, Vol. 05(3) pp. 5
Cole, A. J., 1991, Vol. 05(1) pp. 2
Cole, Gregory A., 2001, Vol. 15(1) pp. 5
Coleman, Doreen, 1990, Vol. 04(3) pp. 6
Coleman, Mary B., 1989, Vol. 03(4) pp. 5
autosomal recessive model for autism, 1997, Vol. 11(2) pp. 3
calcium for self-injury, 1995, Vol. 09(1) pp. 4; 2002, Vol. 16(2) pp. 7.
co-morbid disorders, 1996, Vol. 10(3) pp. 5
diet therapy and PKU, 1989, Vol. 03(4) pp. 2
on Fudenburg, 1989, Vol. 03(4) pp. 1
on lactic acidosis, 1987, Vol. 01(3) pp. 4
NIH's Autism Research Programming, former director, 1989, Vol. 03(2) pp. 7
on pain threshold, 1994, Vol. 08(3) pp. 2
publications, 1993, Vol. 07(2) pp. 7
on purine autism, 1990, Vol. 04(2) pp. 7
Rett's boy, 1991, Vol. 05(2) pp. 4
Ritalin and vitamin B6 compared, 1995, Vol. 09(1) pp. 7
uridine for purine metabolism, 2001, Vol. 15(1) pp. 7
Colglazier, William, 2001, Vol. 15(3) pp. 1
colitis, 2000, Vol. 14(4) pp. 1; 2001, Vol. 15(1) pp. 2.
"collaborative action research," 1994, Vol. 08(2) pp. 2
color-coding, 1990, Vol. 04(2) pp. 5
Combs, Clarice Sue, 1989, Vol. 03(1) pp. 1
Comi, Anne M., 1997, Vol. 11(4) pp. 5
Comings, Brenda G., 1991, Vol. 05(3) pp. 1
Comings, David E., 1990, Vol. 04(3) pp. 5; 1991, Vol. 05(3) pp. 1; 1991, Vol. 05(4) pp. 2; 1992, Vol. 06(2) pp. 4.
Commission for Scientific Medicine and Mental Health, 2005, Vol. 19(2) pp. 3
Committee on Government Reform (U. S. House), 2002, Vol. 16(2) pp. 1
communication books, 1988, Vol. 02(3) pp. 5; 1990, Vol. 04(4) pp. 5.
communication deficits. See also language disorders, speech deficits
animal therapy for, 1989, Vol. 03(4) pp. 2
in autistics' families, 1998, Vol. 12(3) pp. 2
baby talk for, 1989, Vol. 03(2) pp. 5
and behavior, 1994, Vol. 08(4) pp. 3
beta blockers for, 1987, Vol. 01(3) pp. 4
bromacriptine for, 1988, Vol. 02(3) pp. 4
clonidine for, 1992, Vol. 06(3) pp. 2
communication books, 1988, Vol. 02(3) pp. 5; 1990, Vol. 04(4) pp. 5.
conversation prompts for, 1988, Vol. 02(1) pp. 7
diets for, 1999, Vol. 13(2) pp. 6; 2002, Vol. 16(3) pp. 1.
DMG for, 1990, Vol. 04(4) pp. 7; 1993, Vol. 07(1) pp. 7; 1993, Vol. 07(2) pp. 6.
emotion communication, 1990, Vol. 04(3) pp. 4
expressive and instrumental communication compared, 1990, Vol. 04(2) pp. 2
facilitated communication for, 1990, Vol. 04(4) pp. 1; 1992, Vol. 06(3) pp. 3; 1992, Vol. 06(4) pp. 1; 1993, Vol. 07(2) pp. 6; 1993, Vol. 07(3) pp. 6; 1994, Vol. 08(2) pp. 2; 1994, Vol. 08(3) pp. 7.
fenfluramine and, 1987, Vol. 01(3) pp. 2
functional communication, 1992, Vol. 06(1) pp. 5; 1993, Vol. 07(4) pp. 5; 1994, Vol. 08(1) pp. 2; 1996, Vol. 10(4) pp. 2; 2000, Vol. 14(4) pp. 5.
and gene suppression, 1993, Vol. 07(1) pp. 5
immunotherapy for, 1989, Vol. 03(4) pp. 2
inappropriate responses and corpus callosum, 2001, Vol. 15(1) pp. 6
inappropriate speech, 1998, Vol. 12(3) pp. 4; 2002, Vol. 16(4) pp. 5.
incidental language teaching, 1987, Vol. 01(4) pp. 5
L-carnitine for, 1999, Vol. 13(2) pp. 4
L-carnosine for, 2003, Vol. 17(1) pp. 1
magnesium for, 1993, Vol. 07(4) pp. 1; 1994, Vol. 08(1) pp. 7; 1994, Vol. 08(2) pp. 6; 2006, Vol. 20(3) pp. 5.
music for, 1996, Vol. 10(1) pp. 5
naltrexone for, 1990, Vol. 04(4) pp. 4; 2006, Vol. 20(2) pp. 5.
Natural Language Paradigm (NLP) for, 1989, Vol. 03(2) pp. 5
nonverbal deficits, 1990, Vol. 04(2) pp. 2
PECS (Picture Exchange Communication System) for, 1995, Vol. 09(3) pp. 5; 2002, Vol. 16(3) pp. 5; 2002, Vol. 16(4) pp. 2.
pentoxifylline for, 1997, Vol. 11(1) pp. 2
PLAY Project for, 2003, Vol. 17(2) pp. 5
R-THBP for, 2005, Vol. 19(3) pp. 5
routine interruption for, 1989, Vol. 03(3) pp. 5
secretin for, 1998, Vol. 12(2) pp. 1; 2000, Vol. 14(1) pp. 7.
self injury from, 1989, Vol. 03(4) pp. 6
sensory integration for, 1991, Vol. 05(2) pp. 6; 1997, Vol. 11(4) pp. 5.
in siblings of autistics, 1997, Vol. 11(2) pp. 4
sign language for, 1987, Vol. 01(3) pp. 5; 2001, Vol. 15(2) pp. 7.
simultaneous communication, 1996, Vol. 10(1) pp. 5
and sleep problems, 1993, Vol. 07(3) pp. 5
spontaneous communication and, 1988, Vol. 02(1) pp. 6; 1989, Vol. 03(4) pp. 2; 1994, Vol. 08(4) pp. 5.
SSRIs for, 1996, Vol. 10(4) pp. 2
stereotypies from, 1988, Vol. 02(2) pp. 2; 1990, Vol. 04(2) pp. 2.
stimulus overselectivity, 1988, Vol. 02(1) pp. 5
theory of mind and, 1990, Vol. 04(2) pp. 2
two-trainer therapy model for, 2001, Vol. 15(1) pp. 5–6
venlafaxine (Effexor) for, 1996, Vol. 10(4) pp. 2; 2000, Vol. 14(2) pp. 4.
videos for conversation skills, 1990, Vol. 04(1) pp. 5
vitamin B6 for, 1993, Vol. 07(1) pp. 7; 1993, Vol. 07(4) pp. 1; 1994, Vol. 08(2) pp. 6.
and vowel-change perception, 2003, Vol. 17(2) pp. 4
WebTrek Connect, 2001, Vol. 15(3) pp. 5
communication devices
Brother P-Touch Electronic Labeling device, 1992, Vol. 06(4) pp. 3
Canon Communicator, 1988, Vol. 02(1) pp. 3; 1988, Vol. 02(3) pp. 7; 1990, Vol. 04(4) pp. 1; 1991, Vol. 05(1) pp. 1; 1992, Vol. 06(4) pp. 3; 1994, Vol. 08(4) pp. 3.
communication mitt, 1992, Vol. 06(4) pp. 3
Herzog keyboarding system, 1994, Vol. 08(1) pp. 7
IBM Speech Viewer, 1999, Vol. 13(3) pp. 6
Talking Mitt, 1988, Vol. 02(1) pp. 3; 1994, Vol. 08(4) pp. 3.
Talking Typewriter, 1988, Vol. 02(1) pp. 3; 1994, Vol. 08(4) pp. 3.
Communication Unbound (Biklen), 1993, Vol. 07(4) pp. 3; 1994, Vol. 08(2) pp. 2.
community residential care. See also deinstitutionalization movement, group homes
crime in, 2000, Vol. 14(2) pp. 6
as health hazard, 1997, Vol. 11(1) pp. 3
and institutions compared, 1995, Vol. 09(3) pp. 1
mortality rates in, 1996, Vol. 10(3) pp. 7; 1996, Vol. 10(4) pp. 1; 1999, Vol. 13(4) pp. 1.
Community Services for Autistic Adults and Children (CSAAC), 1988, Vol. 02(3) pp. 1
Community Services for Autistic Citizens (CSAC), 1990, Vol. 04(3) pp. 6
Como, Peter, 1991, Vol. 05(4) pp. 2
Complete Guide to Prescription and Non-Prescription Drugs (Griffith), 1997, Vol. 11(2) pp. 7
compliance training, 1994, Vol. 08(1) pp. 5; 1994, Vol. 08(2) pp. 5.
composite woods, 2004, Vol. 18(4) pp. 7
compulsions, 2002, Vol. 16(1) pp. 4; 2003, Vol. 17(1) pp. 6.
computer bulletin boards, 1994, Vol. 08(3) pp. 6; 1994, Vol. 08(4) pp. 7; 1995, Vol. 09(3) pp. 7; 2005, Vol. 19(2) pp. 2. See also databases, websites
computer programs
Fast ForWord, 1997, Vol. 11(4) pp. 1
IBM SpeechViewer, 1999, Vol. 13(3) pp. 6
KidTalk, 2002, Vol. 16(1) pp. 5
Mind Reading, 2003, Vol. 17(2) pp. 5
MISS STIM, 1988, Vol. 02(4) pp. 2
PARLE (Portable Affect Recognition Learning Environment), 2003, Vol. 17(3) pp. 5
virtual reality, 1997, Vol. 11(1) pp. 5; 2002, Vol. 16(3) pp. 5.
Web Trek Connect, 2001, Vol. 15(3) pp. 5
computer websites. See websites
computerized feedback for speech instruction, 1999, Vol. 13(3) pp. 6; 2000, Vol. 14(4) pp. 5.
computers
bulletin boards, 1994, Vol. 08(3) pp. 6; 1994, Vol. 08(4) pp. 7; 1995, Vol. 09(3) pp. 7.
as diagnostic tools, 2001, Vol. 15(1) pp. 3
as language aids, 1988, Vol. 02(1) pp. 3; 1988, Vol. 02(4) pp. 2; 1999, Vol. 13(3) pp. 6; 2000, Vol. 14(4) pp. 5.
concentration, 1990, Vol. 04(4) pp. 7; 1991, Vol. 05(2) pp. 7; 1991, Vol. 05(3) pp. 7; 1993, Vol. 07(2) pp. 6; 1994, Vol. 08(2) pp. 6; 1994, Vol. 08(4) pp. 7; 1999, Vol. 13(2) pp. 6; 2002, Vol. 16(2) pp. 4. See also attention
Concerta, 2006, Vol. 20(1) pp. 5
condiments, 2003, Vol. 17(4) pp. 5
conductive hearing loss, 1988, Vol. 02(2) pp. 5
congenital adrenal hyperphasia (CAH), 1995, Vol. 09(1) pp. 7; 2006, Vol. 20(2) pp. 5.
Congress. See also under U.S.
Congressional operator, 1994, Vol. 08(1) pp. 7; 1994, Vol. 08(2) pp. 2.
connective tissue dysplasia, 1991, Vol. 05(4) pp. 4
connectivity problems, 2004, Vol. 18(3) pp. 2; 2004, Vol. 18(4) pp. 5.
Connolly, A. M., 1999, Vol. 13(2) pp. 4
Connors, Susan L., 2004, Vol. 18(4) pp. 7
Consensus Conference on the Detoxification of Autistic Children, 2001, Vol. 15(1) pp. 1
Consensus Development Conference on the Treatment of Destructive Behaviors, 1989, Vol. 03(4) pp. 1; 1990, Vol. 04(1) pp. 6.
Constantino, John N., 2002, Vol. 16(2) pp. 4
constipation
from drugs, 2001, Vol. 15(1) pp. 4; 2002, Vol. 16(1) pp. 3; 2003, Vol. 17(1) pp. 6.
megarectum from, 2003, Vol. 17(4) pp. 5
from milk intake, 2003, Vol. 17(4) pp. 5
and self-injury, 2003, Vol. 17(1) pp. 7
contraceptives
Depo Provera, 1999, Vol. 13(2) pp. 7; 2003, Vol. 17(1) pp. 4.
Norplant, 1995, Vol. 09(4) pp. 4; 1996, Vol. 10(2) pp. 4; 2003, Vol. 17(1) pp. 4.
for PMS, 1999, Vol. 13(2) pp. 7; 2000, Vol. 14(3) pp. 5.
and Rimactane, 1996, Vol. 10(3) pp. 4
and Tegretol, 1996, Vol. 10(3) pp. 4
conversation training
Cook, Edwin H., Jr.
autism gene not yet found, 2001, Vol. 15(2) pp. 6
chromosome 15 defect as imprinted gene, 1997, Vol. 11(4) pp. 4; 1998, Vol. 12(3) pp. 4; 1999, Vol. 13(2) pp. 4.
depression and serotonin in autistics' parents, 1994, Vol. 08(3) pp. 4
Prozac studies, 1992, Vol. 06(3) pp. 4; 1993, Vol. 07(3) pp. 2.
serotonin transporter gene and autism, 1997, Vol. 11(2) pp. 2; 1997, Vol. 11(4) pp. 2; 2000, Vol. 14(1) pp. 1.
cookbooks, 1989, Vol. 03(3) pp. 5
Cooke, L. B., 1999, Vol. 13(1) pp. 4
cooking, 1989, Vol. 03(3) pp. 5
Cooper, Louis Z., 2001, Vol. 15(3) pp. 2
coordination
in Asperger's and high-functioning autism compared, 1995, Vol. 09(2) pp. 6
and brain abnormalities, 1994, Vol. 08(2) pp. 1; 1997, Vol. 11(2) pp. 4.
chromosome 15, 1994, Vol. 08(3) pp. 4
and diphenydramine citrate or diphenhydramine hydrochloride, 2003, Vol. 17(1) pp. 5
DMG for, 1992, Vol. 06(2) pp. 6; 1993, Vol. 07(2) pp. 6.
in dyslexics, 2000, Vol. 14(4) pp. 6
and facilitated communication, 1993, Vol. 07(3) pp. 3
and fenfluramine, 1987, Vol. 01(3) pp. 2
gluten-free diet for, 1999, Vol. 13(2) pp. 6
lamotrigine for Rett's, 1998, Vol. 12(2) pp. 5
and mercury, 2000, Vol. 14(2) pp. 7; 2003, Vol. 17(2) pp. 7.
motion perception and gait, 1995, Vol. 09(4) pp. 5
motor delays in Asperger's babies, 2004, Vol. 18(3) pp. 5
postural difficulties, 2004, Vol. 18(4) pp. 5
in schizophrenic plus autistic patients, 1989, Vol. 03(4) pp. 4
sensory integration therapy for, 1988, Vol. 02(2) pp. 6; 1991, Vol. 05(2) pp. 3.
special friends for, 1990, Vol. 04(1) pp. 5
supplements for, 1992, Vol. 06(2) pp. 6; 1993, Vol. 07(4) pp. 6; 1994, Vol. 08(1) pp. 7; 2002, Vol. 16(2) pp. 2.
and vision abnormalities, 1997, Vol. 11(3) pp. 5; 1999, Vol. 13(3) pp. 6.
Coplan, James, 1995, Vol. 09(2) pp. 6
Coplan, Myron, 1998, Vol. 12(4) pp. 5
copper, 2001, Vol. 15(2) pp. 4; 2003, Vol. 17(1) pp. 1.
Coppola, G., 2002, Vol. 16(2) pp. 5
COPRO (coproporphyrin). See coproporphyrin
coprolalia, 1994, Vol. 08(2) pp. 5
coprophragia, 2001, Vol. 15(1) pp. 7
coproporphyrin (COPRO), 2006, Vol. 20(2) pp. 1
cord clamping, 2004, Vol. 18(1) pp. 6
corneal ulcers, 1998, Vol. 12(3) pp. 4
corpus callosum
corpus striatum, 1989, Vol. 03(2) pp. 4
correspondence training/visual feedback (CTVF), 1991, Vol. 05(4) pp. 5
cortex, 1990, Vol. 04(3) pp. 4; 1995, Vol. 09(3) pp. 4.
asymmetry of, 2002, Vol. 16(4) pp. 4
and communication skills, 2001, Vol. 15(4) pp. 4
inflammation in, 2004, Vol. 18(4) pp. 1
reorganization in savants, 1989, Vol. 03(1) pp. 7
and speech in Landau-Kleffner syndrome, 1991, Vol. 05(1) pp. 2
corticosteroids
cortisol, 1991, Vol. 05(2) pp. 5
Costa, Erminio, 2001, Vol. 15(2) pp. 1
Cott, Allan, 1990, Vol. 04(2) pp. 3
Cott, Jerry, 1999, Vol. 13(1) pp. 7
cough medicine, 2005, Vol. 19(3) pp. 2
Coulson, Michael, 1993, Vol. 07(1) pp. 7
Coulter, David M., 2002, Vol. 16(1) pp. 4
Coulter, Harris L., 1995, Vol. 09(1) pp. 1; 1998, Vol. 12(1) pp. 3.
Council for Exceptional Children, 1993, Vol. 07(4) pp. 2
Council for Learning Disabilities, 1993, Vol. 07(4) pp. 2
country living. See rural alternative
Courchesne, Eric
attention-deficit studies, 1990, Vol. 04(2) pp. 4
brainstem evoked potential (BAEP) findings, 1992, Vol. 06(4) pp. 1
on cerebellum defects, 1987, Vol. 01(1) pp. 1; 1988, Vol. 02(2) pp. 1; 1988, Vol. 02(4) pp. 1; 1989, Vol. 03(3) pp. 4; 1991, Vol. 05(2) pp. 4; 1994, Vol. 08(2) pp. 1; 1995, Vol. 09(2) pp. 1; 1997, Vol. 11(2) pp. 4; 2000, Vol. 14(3) pp. 4.
cortex findings, 1990, Vol. 04(3) pp. 4
head growth in autistics, 2003, Vol. 17(3) pp. 2
parietal lobe findings, 1993, Vol. 07(3) pp. 4; 1994, Vol. 08(3) pp. 5.
court/legal cases
Access to Medical Treatment Act, 1997, Vol. 11() pp. 3 See also legislation)
Autism Research Institute versus Autism Society of America, 1995, Vol. 09(2) pp. 3
Benefit Trust Life Insurance Company, 1991, Vol. 05(2) pp. 6; 1997, Vol. 11(3) pp. 3.
Brown versus Board of Education, 1993, Vol. 07(4) pp. 2
Coalition for SAFE Minds, 2000, Vol. 14(4) pp. 7; 2001, Vol. 15(3) pp. 2.
on facilitated communication, 1993, Vol. 07(1) pp. 7; 1993, Vol. 07(2) pp. 7; 2000, Vol. 14(2) pp. 5.
Frye and Daubert Hearings, 1993, Vol. 07(2) pp. 7; 2000, Vol. 14(2) pp. 5.
Judge Rotenberg Educational Center versus Massachusetts Department of Mental Retardation, 1995, Vol. 09(4) pp. 2; 1997, Vol. 11(3) pp. 5.
The Lancet versus Wakefield, Andrew, 2004, Vol. 18(1) pp. 1
on Lovaas method, 1998, Vol. 12(2) pp. 6
on measles-mumps-rubella vaccine, 1999, Vol. 13(2) pp. 7; 2000, Vol. 14(3) pp. 1.
Rain Man lawsuit, 1995, Vol. 09(2) pp. 3
vaccine injury lawsuit, 2001, Vol. 15(1) pp. 2; 2001, Vol. 15(4) pp. 1.
courtesy stigma, 1993, Vol. 07(3) pp. 5
Coyle, Caryn, 1988, Vol. 02(3) pp. 2
CPF (organosphosphate insecticide chlorpyrifos), 2004, Vol. 18(3) pp. 6
cream, anesthetic, 2003, Vol. 17(4) pp. 5
creatine, 1999, Vol. 13(3) pp. 4; 2003, Vol. 17(3) pp. 4; 2005, Vol. 19(3) pp. 7.
Creedon, Margaret, 2006, Vol. 20(2) pp. 3
Creel, Donnell J., 1989, Vol. 03(3) pp. 4
Cries from the Heart (CBS movie), 1994, Vol. 08(3) pp. 7
crime, 1988, Vol. 02(4) pp. 7; 2000, Vol. 14(2) pp. 6.
Crisp, A. G., 1988, Vol. 02(3) pp. 5
Critchley, H. D., 2000, Vol. 14(4) pp. 2
Crohn's disease, 1996, Vol. 10(4) pp. 1; 1998, Vol. 12(1) pp. 6; 2000, Vol. 14(2) pp. 7; 2005, Vol. 19(2) pp. 2; 2006, Vol. 20(2) pp. 5. See also inflammatory bowel disease
Cronister, Amy, 1989, Vol. 03(2) pp. 2
Crook, William G., 1988, Vol. 02(2) pp. 3; 1989, Vol. 03(1) pp. 6; 1989, Vol. 03(2) pp. 3; 2002, Vol. 16(3) pp. 7.
Croonenberghs, J., 2002, Vol. 16(4) pp. 4
cross-reactive peptides, 2002, Vol. 16(3) pp. 6
crossed eyes. See strabismus
Crossley, Rosemary
DEAL Communication Center, 1990, Vol. 04(4) pp. 1; 1992, Vol. 06(3) pp. 1; 1993, Vol. 07(3) pp. 3; 2005, Vol. 19(2) pp. 3.
on facilitated communication, 1994, Vol. 08(2) pp. 2
on facilitated-communication evaluation, 1992, Vol. 06(4) pp. 2
on independent typing's first case, 1994, Vol. 08(1) pp. 7
Intellectual Disability Review Panel of Victoria's study of DEAL, 1991, Vol. 05(1) pp. 1; 1991, Vol. 05(2) pp. 6.
PBS Frontline show on, 1993, Vol. 07(3) pp. 1
and sexual abuse allegations, 1992, Vol. 06(1) pp. 1
St. Nicholas Hospital's investigation of DEAL, 1991, Vol. 05(1) pp. 6; 1991, Vol. 05(2) pp. 6.
on touch and communication, 1991, Vol. 05(4) pp. 3
crossword puzzle as science metaphor, 2000, Vol. 14(4) pp. 3
Crowell, Beth, 2004, Vol. 18(3) pp. 6
crying, inappropriate, 2005, Vol. 19(4) pp. 5
crypto savants, 1990, Vol. 04(1) pp. 3; 1991, Vol. 05(4) pp. 3; 2005, Vol. 19(2) pp. 3.
CSAAC (Community Services for Autistic Adults and Children), 1988, Vol. 02(3) pp. 1
CSAC (Community Services for Autistic Citizens), 1990, Vol. 04(3) pp. 6
CTVF (Correspondence Training/Visual Feedback), 1991, Vol. 05(4) pp. 5
Cuccaro, Michael L., 2003, Vol. 17(1) pp. 6
cueing for tooth-grinding, 1988, Vol. 02(4) pp. 5
cues-pause-point technique, 1987, Vol. 01(3) pp. 5
Cummins, Robert, 1991, Vol. 05(1) pp. 6; 1991, Vol. 05(2) pp. 6; 1992, Vol. 06(1) pp. 3; 1992, Vol. 06(3) pp. 1.
Cuomo, Vincenzo, 2003, Vol. 17(1) pp. 4
Curran, Laura Kresch, 2005, Vol. 19(3) pp. 5
Curtin, Jean M., 1991, Vol. 05(2) pp. 7
cussing, 1994, Vol. 08(2) pp. 5
Cutler, Paul, 2005, Vol. 19(4) pp. 3
Cuvo, Anthony J., 2001, Vol. 15(3) pp. 5
cyanocobalamin, 2005, Vol. 19(4) pp. 3
Cylert (pemoline), 2000, Vol. 14(1) pp. 2; 2005, Vol. 19(3) pp. 4.
CYP3A4, 1997, Vol. 11(3) pp. 6
cysteine, 2005, Vol. 19(1) pp. 2; 2005, Vol. 19(4) pp. 3; 2006, Vol. 20(4) pp. 4.
cytochalasin B block micronucleus test, 2003, Vol. 17(1) pp. 2
cytochrome P450 enzyme, 2002, Vol. 16(4) pp. 6
cytokines, 2004, Vol. 18(4) pp. 1; 2005, Vol. 19(1) pp. 4; 2005, Vol. 19(2) pp. 1; 2006, Vol. 20(4) pp. 6.
cytomegalovirus (CMV), 1990, Vol. 04(4) pp. 4; 1991, Vol. 05(4) pp. 2.